Unknown

Dataset Information

0

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35.


ABSTRACT: Oncolytic adenoviruses (OAds) are among the most promising oncolytic viruses. Almost all oncolytic adenoviruses are composed of human adenovirus serotype 5 (Ad5) (OAd5). However, expression of the primary infection receptor for Ad5, coxsackievirus-adenovirus receptor (CAR), often declines on malignant tumor cells, resulting in inefficient infection in CAR-negative tumor cells. In addition, at least 80% of adults have neutralizing antibodies against Ad5. In this study, we developed a novel OAd fully composed of OAd35. OAd35 recognizes CD46, which is ubiquitously expressed on almost all human cells and is often upregulated on malignant tumor cells, as an infection receptor. Moreover, 20% or fewer adults have neutralizing antibodies against Ad35. OAd35 mediated efficient cell lysis activities at levels similar to OAd5 in CAR-positive tumor cells, while OAd35 showed higher levels of cell lysis activities than OAd5 in CAR-negative tumor cells. Anti-Ad5 serum significantly inhibited in vitro tumor cell lysis activities of OAd5, whereas OAd35 exhibited comparable levels of in vitro tumor cell lysis activities in the presence of anti-Ad5 and naive serum. OAd35 significantly suppressed growth of the subcutaneous CAR-positive and CAR-negative tumors following intratumoral administration. These results indicated that OAd35 is a promising alternative oncolytic virus for OAd5.

SUBMITTER: Ono R 

PROVIDER: S-EPMC7878985 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35.

Ono Ryosuke R   Takayama Kosuke K   Sakurai Fuminori F   Mizuguchi Hiroyuki H  

Molecular therapy oncolytics 20210126


Oncolytic adenoviruses (OAds) are among the most promising oncolytic viruses. Almost all oncolytic adenoviruses are composed of human adenovirus serotype 5 (Ad5) (OAd5). However, expression of the primary infection receptor for Ad5, coxsackievirus-adenovirus receptor (CAR), often declines on malignant tumor cells, resulting in inefficient infection in CAR-negative tumor cells. In addition, at least 80% of adults have neutralizing antibodies against Ad5. In this study, we developed a novel OAd fu  ...[more]

Similar Datasets

| S-EPMC3437574 | biostudies-literature
| S-EPMC4433270 | biostudies-literature
| S-EPMC5353943 | biostudies-literature
| S-EPMC4648371 | biostudies-literature
| S-EPMC2169084 | biostudies-literature
| S-EPMC9131115 | biostudies-literature
| S-EPMC3778061 | biostudies-literature
| S-EPMC5356712 | biostudies-literature
| S-EPMC2568953 | biostudies-literature
| S-EPMC2951567 | biostudies-literature